Physician profile
Karie E Jeter
NPI 1376076141
$6,975.41
in general payments reported to CMS, 2019-2025
13 companies · $3,284 in 2025
The $3,284 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,692 · 2025: $3,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $773 · Travel and Lodging: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $772.59 |
| Travel and Lodging | $202.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,333.85 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $155.07 | 2024 | |
| Mimedx Group, INC. | $138.95 | 2024 | |
| Heron Therapeutics, INC. | $125.00 | 2024 | Zynrelef |
| Solventum Corporation | $49.30 | 2024-2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Becton, Dickinson and Company | $35.36 | 2025 | Hemosphere |
| Stryker Corporation | $26.13 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Conmed Corporation | $24.20 | 2025 | Conmed Specimen Retrieval, Airseal |
| Boston Scientific Corporation | $23.45 | 2025 | Varithena Administration Pack |
| Neuros Medical, INC. | $19.52 | 2025 | Altius |
| Vertex Pharmaceuticals Incorporated | $17.04 | 2025 | |
| Integra Lifesciences Corporation | $13.78 | 2024 | Integra, Omnigraft, Surgimend |
| Myriad Genetic Laboratories, INC. | $13.76 | 2025 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karie Jeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.